Table 5.

Clinical and pathologic features for all 33 patients diagnosed with breast cancer

Patient	Age at HL tx	XRT Dose (Gy)	Chemo	Age at BC	Attribution	Histology	Grade	Tumor (cm)	ER status	PR Status	Her2/neu status
1 (L)	10	-*	None	37	mammo	DCIS	2	6.3	neg	neg	-
1 (R)	10	-	None	37	palpation	IDC	-	3.0	neg	neg	pos
2	13	-	-	34	mammo	DCIS	2	9.7	pos	pos	-
3	14	-	None	47	mastectomy	IDC	2	1.0	pos	pos	neg
4	16	-	PAVe	35	mammo	IDC	3	2.1	neg	neg	-
5	16	-	ABVD	42	mammo	DCIS	2	1.4	pos	pos	neg
6	17	44	MOPP	44	mammo	IDC	1	2.2	pos	pos	neg
7	18	44	ABVD	34	mammo	DCIS	-	-	-	-	-
8	21	44	-	54	mammo	DCIS	3	1.8	pos	pos	-
9	21	44	None	42	mammo	IDC	3	1.2	neg	neg	neg
10	21	-	None	38	mammo	DCIS	3	1.5	pos	pos	-
11 (L)	21	44	MOPP	53	palpation	IDC/DCIS	3	3.0	neg	neg	neg
11 (R)	21	44	MOPP	53	palpation	IDC/DCIS	2	1.2	pos	pos	neg
12	21	36	Stanford V	35	palpation	IDC/DCIS	2	2.0	pos	pos	neg
13	22	44	PAVe	53	mammo	IDC	2	1.8	pos	neg	neg
14	23	-	ABVD	44	mammo	IDC/DCIS	2	1.0	pos	pos	neg
15	23	44	MOPP	58	PET	IDC	2	1.3	neg	neg	neg
16	24	44	None	50	palpation	IDC/DCIS	1	1.8	pos	neg	-
17	24	43.2	MOPP	43	mammo	IDC	2	1.8	pos	pos	neg
18	25	43.8	PAVe	41	mammo	DCIS	3	0.5	-	-	-
19	25	44	None	61	mammo	DCIS	3	3.5	pos	pos	-
20	27	45	ABVD/MOPP	36	palpation	IDC	2	1.5	neg	neg	-
21	28	-	-	46	palpation	DCIS	3	2.7	-	-	-
22	29	36	Stanford V	40	mammo	DCIS	3	1.8	neg	neg	-
23	30	44	MOPP	66	mammo	IDC/DCIS	3	4.0	pos	pos	neg
24	30	44	-	50	mammo	IDC/DCIS	2	1.4	pos	pos	neg
25	31	44	MOPP	56	mammo	IDC	2	1.8	neg	neg	neg
26	32	44	None	50	palpation	IDC	3	1.5	neg	neg	-
27	33	43.6	ABVD	44	palpation	IDC	1	2.2	neg	neg	neg
28	33	45	PAVe	57	mammo	IDC	3	2.0	pos	neg	neg
29	33	44	None	42	palpation	IDC	2	2.0	neg	neg	neg
30	34	44	None	51	mammo	IDC/DCIS	2	0.6	neg	neg	pos
31	35	44	ABVD	57	mammo	IDC	2	1.2	pos	pos	neg
32	38	30	Stanford V	44	mammo	IDC	2	3.3	pos	pos	neg
33	48	44	MOPP	79	mammo	DCIS	2	0.2	pos	pos	-

^*Information was unavailable